Haemonetics (HAE) Other financing activities (2009 - 2026)

Haemonetics has reported Other financing activities for 18 years, with the latest figure at $426000.0 in Q2 2026.

• On a quarterly basis, Other financing activities fell 7.79% year-over-year to $426000.0 in Q2 2026; TTM through Jun 2026 was -$138000.0, a 81.55% increase from a year earlier, with the FY2026 full-year figure at -$102000.0, up 59.04% from the prior year.
• Other financing activities was $426000.0 for Q2 2026 at Haemonetics, up from -$1.8 million in the prior quarter.
• The five-year high for Other financing activities was $2.2 million in Q4 2022, with the low at -$2.5 million in Q2 2023.
• Average Other financing activities over 5 years is -$6421.1, with a median of $251000.0 recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Other financing activities tumbled 779.53% in 2023, then soared 211.36% in 2024.
• Over 5 years, Other financing activities stood at $160000.0 in 2022, then grew by 16.25% to $186000.0 in 2023, then surged by 171.51% to $505000.0 in 2024, then jumped by 127.13% to $1.1 million in 2025, then plunged by 62.86% to $426000.0 in 2026.
• The last three Other financing activities figures came in at $426000.0 (Q2 2026), -$1.8 million (Q1 2026), and $1.1 million (Q4 2025), per Business Quant data.